BLUE Jan 2024 10.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Al 10:31AM EDT. Mercato aperto.
Il grafico dei titoli non è supportato dal tuo browser attuale
| Chiusura precedente | 0,2800 |
| Aperto | 0,2800 |
| Denaro | 0,0000 |
| Lettera | 0,0000 |
| Prezzo d'esercizio | 10,00 |
| Scadenza | 2024-01-19 |
| Min-Max giorno | 0,2800 - 0,2800 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 2,55k |
GlobeNewswireReal Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLOFLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to provide multiple health plans with access to an innovative, outcomes-based agreement for ZYNTEGLO® (betibeglogene autotem